398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States

por Bauer, Karri A, Yu, Kalvin, Gupta, Vikas, Puzniak, Laura A
Publicado 2021

156. Evaluation of Trends in Antimicrobial Use and Proportion of Culture Positive Gram-Negative/Gram-Positive Pathogens Comparing Prior to and During the SARS-CoV-2 Pandemic: A Mul...

por Puzniak, Laura A, Bauer, Karri A, Yu, Kalvin, Gupta, Vikas
Publicado 2021

103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs

por Klinker, Kenneth, Bauer, Karri A, DeRyke, C Andrew, Hidayat, Levita K
Publicado 2020

221. Evaluation of Rates of Culture Positive Blood Stream Pathogens Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation

por Puzniak, Laura A, Bauer, Karri A, Yu, Kalvin, Moise, Pamela, Gupta, Vikas
Publicado 2021

Pharmacokinetic/pharmacodynamic predictions and clinical outcomes of patients with augmented renal clearance and Pseudomonas aeruginosa bacteremia and/or pneumonia treated with ext...

por Gerlach, Anthony T., Wenzler, Eric, Hunt, Lauren N., Bazan, Jose A., Bauer, Karri A.
Publicado 2019

Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials

por Wenzler, Eric, Wong, Jordan R., Goff, Debra A., Jankowski, Christopher A., Bauer, Karri A.
Publicado 2016

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020

por Finelli, Lyn, Gupta, Vikas, Petigara, Tanaz, Yu, Kalvin, Bauer, Karri A., Puzniak, Laura A.
Publicado 2021

127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection

por Bauer, Karri A, Hidayat, Levita K, Klinker, Kenneth, Motyl, Mary, Andrew DeRyke, C
Publicado 2021

151. Simplifying Empiric Antimicrobial Therapy Selection for Lower Respiratory Tract Infections in Intensive Care Unit Patients: Using Resistance Frequency to Guide Decision Making

por Klinker, Kenneth, Hidayat, Levita K, Andrew DeRyke, C, Motyl, Mary, Bauer, Karri A
Publicado 2021

Impact of formulary restriction with prior authorization by an antimicrobial stewardship program

por Reed, Erica E., Stevenson, Kurt B., West, Jessica E., Bauer, Karri A., Goff, Debra A.
Publicado 2013

A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves

por Puzniak, Laura A., Bauer, Karri A., Yu, Kalvin C., Watts, Janet A., Ai, ChinEn, Gupta, Vikas
Publicado 2023

Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms

por Klinker, Kenneth P., Hidayat, Levita K., DeRyke, C. Andrew, DePestel, Daryl D., Motyl, Mary, Bauer, Karri A.
Publicado 2021

1671. Activity of Imipenem/Relebactam and Comparators Against Gram-Negative MDR and DTR Pathogens from Patients with Respiratory and Bloodstream Infections – SMART United States 20...

por Lob, Sibylle, Hackel, Meredith, Siddiqui, Fakhar, Bauer, Karri A, DeRyke, Charles A, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2022

1670. Activity of Ceftolozane/Tazobactam and Comparators Against Clinical MDR and DTR Pseudomonas aeruginosa isolates – SMART United States 2018-2020

por Lob, Sibylle, Hackel, Meredith, Siddiqui, Fakhar, Bauer, Karri A, DeRyke, Charles A, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2022

379. Epidemiology of Antimicrobial Use Among SARS-CoV-2 Positive and Negative Admissions in the US: A Multicenter Evaluation

por Puzniak, Laura A, Bauer, Karri A, Finelli, Lyn, De Anda, Carisa, Moise, Pamela, Yu, Kalvin, Vankeepuram, Latha, Parikh, Prashant, Gupta, Vikas
Publicado 2020

373. Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation

por Puzniak, Laura A, Finelli, Lyn, Bauer, Karri A, Moise, Pamela, Yu, Kalvin, De Anda, Carisa, Vankeepuram, Latha, Parikh, Prashant, Gupta, Vikas
Publicado 2020

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19

por Puzniak, Laura, Finelli, Lyn, Yu, Kalvin C., Bauer, Karri A., Moise, Pamela, De Anda, Carisa, Vankeepuram, Latha, Sepassi, Aryana, Gupta, Vikas
Publicado 2021

Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation...

por Puzniak, Laura, Bauer, Karri A, Yu, Kalvin C, Moise, Pamela, Finelli, Lyn, Ye, Gang, De Anda, Carisa, Vankeepuram, Latha, Gupta, Vikas
Publicado 2021

Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States

por Klinker, Kenneth P., Hidayat, Levita K., Wenzler, Eric, Balada-Llasat, Joan-Miquel, Motyl, Mary, DeRyke, C. Andrew, Bauer, Karri A.
Publicado 2022

Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation

por Bauer, Karri A., Puzniak, Laura A., Yu, Kalvin C., Finelli, Lyn, Moise, Pamela, Ai, ChinEn, Watts, Janet A., Gupta, Vikas
Publicado 2022